These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5443539)

  • 1. Intensive cyclophosphamide therapy in advanced malignant disease.
    Binns JH; Southall AC
    Practitioner; 1970 Apr; 204(222):546-8. PubMed ID: 5443539
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclophosphamide in the management of advanced breast cancer.
    Joslin CA; Kunkler PB; Evans IH; Jones V; Wong K
    Proc R Soc Med; 1970 Jan; 63(1):81-4. PubMed ID: 5417790
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
    Schubert JC; Ischer M; Hilbert L
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of disulfiram on cyclophosphamide toxicity: a clinical trial.
    Ershler WB; Hacker MP; Newman RA; Stewart JA; Gamelli RL; Krakoff IH
    Cancer Treat Rep; 1983 Dec; 67(12):1145-7. PubMed ID: 6652633
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of 126 cases of advanced ovarian carcinoma with cyclophosphamide.
    Beck RE; Boyes DA
    Can Med Assoc J; 1968 Mar; 98(11):539-41. PubMed ID: 5647240
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the question of intestinal absorption disorders in drug therapy of neoplasms].
    Neumeister K; Cilensek M
    Dtsch Gesundheitsw; 1968 Nov; 23(47):2239-40. PubMed ID: 5732684
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitoxantrone and cyclophosphamide in patients with advanced breast cancer.
    Ehninger G; Weible KH; Heidemann EG; Waller HD
    Cancer Treat Rep; 1984 Oct; 68(10):1283-4. PubMed ID: 6525600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxorubicin and cyclophosphamide chemotherapy for disseminated endometrial cancer.
    Seski JC; Edwards CL; Gershenson DM; Copeland LJ
    Obstet Gynecol; 1981 Jul; 58(1):88-91. PubMed ID: 7195533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hair melanogenesis in endoxan alopecia and its modification by corticosteroids].
    Kostanecki W; Kwiatkowska E; Zborzil J
    Arch Klin Exp Dermatol; 1966 Sep; 226(1):13-20. PubMed ID: 5995016
    [No Abstract]   [Full Text] [Related]  

  • 11. Variation in the WBC differential count and other factors associated with reporting of herpes labialis: a population-based study of adults.
    Parks CG; Andrew ME; Blanciforti LA; Luster MI
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):336-43. PubMed ID: 17727654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide therapy of peripheral uveitis.
    Buckley CE; Gills JP
    Arch Intern Med; 1969 Jul; 124(1):29-35. PubMed ID: 5791483
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cyclophosphamide therapy in malignant diseases. Experience from a 10 year period in a medical department].
    Laursen ML
    Ugeskr Laeger; 1972 Feb; 134(6):269-73. PubMed ID: 5010245
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
    Drummond KN; Hillman DA; Marchessault JH; Feldman W
    Can Med Assoc J; 1968 Mar; 98(11):524-31. PubMed ID: 5643296
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
    de Jonge ME; Mathôt RA; Dalesio O; Huitema AD; Rodenhuis S; Beijnen JH
    Bone Marrow Transplant; 2002 Nov; 30(9):593-7. PubMed ID: 12407434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced malignant neoplasms with cyclophosphamide An evaluation].
    Singer Z; Rozek-Lesiak K; Swierczyńska B
    Wiad Lek; 1976 Jun; 29(12):1085-91. PubMed ID: 951984
    [No Abstract]   [Full Text] [Related]  

  • 17. [Shock doses of endoxan in the therapy of malignant lung neoplasms (based on personal observations)].
    Ratajek M
    Wiad Lek; 1970 Jan; 23(1):15-8. PubMed ID: 5412426
    [No Abstract]   [Full Text] [Related]  

  • 18. [Polychemotherapy of the advanced stages of malignant proliferative disorders].
    Fazio M; Bachi C; Cavallero P; Sartoris S; Vergnano F
    Minerva Med; 1971 Apr; 62(33):1699-705. PubMed ID: 5577301
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute hematologic feasibility of G-CSF supported dose-escalated FEC therapy as adjuvant treatment after breast cancer surgery.
    Ottosson S; Magnusson K; Hultborn R
    Anticancer Res; 1999; 19(5C):4429-34. PubMed ID: 10650787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanonychia after treatment of malignant disease with radiation and cyclophosphamide.
    Inalsingh CH
    Arch Dermatol; 1972 Nov; 106(5):765-6. PubMed ID: 4635808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.